Atlas Trials

Jonathan Riess

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Jonathan Riess

RecordFirmDate
Osimertinib, Cetuximab, and Tucatinib for the Treatment of EGFR-Mutant Stage IV or Recurrent Non-small Lung Cell Cancer (NCT06067776)Jonathan Riess2024-01-01
Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations (NCT03299088)Jonathan Riess2018-06-26
Pembrolizumab and Afatinib in Patients With Non-small Cell Lung Cancer With Resistance to Erlotinib (NCT02364609)Jonathan Riess2015-09-30

Track Jonathan Riess automatically

Every clearance here is in the API, with alerts when new ones post.